Under pressure to develop treatments for recurrent cancers with a high rate of fatality, cancer researchers are revisiting old treatment strategies to see if the application of new medical techniques and improved medical technology might make these strategies viable cancer treatment options again. Repeat radiation is one of these old treatments undergoing new life.
High Risk of Injury is a Problem
Significant improvement in the precision of radiation targeting has led a small number of cancer centers to experiment with repeat radiation on Stage 4 lung cancer patients who are out of options. Re-irradiation uses high-level doses of radiation but employs new techniques to tightly target the tumor and minimize damage to surrounding tissues. Despite precautions, repeat radiation does carry a high risk of serious injury to the patent which seems to be the reason few cancer centers are experimenting with the procedure.
No Risk Alternatives for Continued Lung Cancer Treatment
Using another treatment on the comeback trail, lung cancer patients undergoing non-toxic autologous cancer treatments are achieving positive results without re-irradiation’s considerable risks. Autologous cancer vaccines that use the patient’s own blood to boost immune system function have been used with success at Issels alternative cancer treatment centers for decades. Although the use of autologous vaccines has been in use for decades, it is back in the spotlight in the wake of new discoveries revealing the complicated cellular interactions between cancer tumors and immune system cells.
Stage 4 Lung Cancer Remission Success
Despite its effectiveness among various cancers and stages, individualized integrative immunotherapy is another cancer treatment strategy that has been gaining traction in mainstream cancer medicine. Find out more about how integrative immunotherapy is being used to successfully combat Stage 4 lung cancer.